Previous Article | Next Article ![]()
Infection and Immunity, July 2000, p. 4303-4311, Vol. 68, No. 7
Departments of
Pediatrics1 and Microbiology & Immunology4 and Sealy Center for
Molecular Sciences,5 University of Texas
Medical Branch, Galveston, Texas, 77555-0366; Department of
Medical Microbiology and Immunology, University of Göteborg,
Göteborg, Sweden2; and
Department of Medicine, National University of Ireland, Cork,
Ireland3
Received 22 December 1999/Returned for modification 22 February
2000/Accepted 20 April 2000
Helicobacter pylori causes a common chronic infection
of humans that leads to epithelial cell damage. Studies have shown that apoptosis of the gastric epithelium is increased during infection and
this response is associated with an expansion of gastric
T-helper type 1 (Th1) cells. We report that gastric T cells
contribute to apoptosis of the epithelium by a Fas/Fas
ligand (FasL) interaction. Fas receptor expression was detected on
freshly isolated gastric epithelial cells by flow cytometry and
immunohistochemistry, and this level of expression was increased during
infection with H. pylori. The expression of Fas receptor on
three gastric epithelial cell lines was increased by H. pylori, either alone or in combination with gamma interferon or
tumor necrosis factor alpha. The role of Fas in apoptosis of
gastric epithelial cell lines was evidenced by DNA fragmentation
after cross-linking of Fas with specific antibodies. FasL
expression was detected by immunohistochemistry on
mononuclear cells in gastric biopsy specimens of infected
but not uninfected subjects. Gastric T-cell lines were also shown to express FasL, as evidenced by reverse transcription-PCR and killing of target cells expressing Fas receptor.
Moreover, these T-cell lines were capable of killing cultured gastric
epithelial target cells and antibodies that block the interaction
between Fas receptor and FasL inhibited this cytotoxic activity.
These observations demonstrate that local Th1 cells may
contribute to the pathogenesis of gastric disease during H. pylori infection by increasing the expression of Fas on
gastric epithelial cells and inducing apoptosis through Fas/FasL interactions.
Helicobacter pylori
causes a lifelong infection of the gastric antrum that affects more
than 50% of humanity. Infection is associated with chronic antral
gastritis, characterized by a mucosal infiltration of polymorphonuclear
and mononuclear leukocytes (10, 14). Evidence for a
pathogenic role of H. pylori infection in peptic ulcer
is derived from clinical investigations showing that cure of
H. pylori infection accelerates ulcer healing and
prevents ulcer relapse (20). Besides ulcer disease,
H. pylori infection has also been implicated as a cause
of gastric lymphoma or carcinoma in some patients (7).
There are many reports that H. pylori infection
interferes with the equilibrium between proliferation and
apoptosis of the gastric epithelium (4, 7, 25, 32, 35,
49). Most of the in situ studies have shown that the number of
apoptotic epithelial cells increases during H. pylori
infection (25, 32, 35, 41). Numerous mechanisms could
account for this, including the direct effects of the bacteria, as well
as the inflammatory response elicited by the infection (13, 24,
41, 49).
Several independent approaches have suggested that T-helper type 1 (Th1) cells are selectively increased during infection (3, 9, 18,
26, 31). Th1 cytokines, such as gamma interferon (IFN- Th1 cells can also express higher levels of FasL than Th2 cells
(40, 46). This molecule belongs to the TNF family of
proteins. The receptor of FasL, Fas (CD95), is a 45-kDa protein
belonging to the TNF receptor family. Cross-linking of Fas with an
agonistic immunoglobulin M (IgM) antibody or FasL will transduce the
death signal to the cells, resulting in the induction of
apoptosis. However, studies to date have not shown that gastric
T cells express FasL and induce epithelial cell death by Fas/FasL
interactions. The purpose of this study was to investigate the role of
H. pylori in the modulation of lymphoepithelial
interactions in the stomach that are mediated through Fas/FasL.
Subjects.
Material from human tissue was obtained from
consenting adults aged 20 to 55 years as approved by the respective
institutional review boards at the National University of Ireland, the
University of Göteborg, and the University of Texas Medical
Branch. Individuals regularly using nonsteroidal anti-inflammatory
drugs or antisecretory drugs were excluded from the study population.
Biopsy specimens of the gastric antrum were obtained from consenting
subjects undergoing gastroesophageal duodenoscopy for various clinical
indications. Subjects were considered infected if H. pylori was detected either by a rapid urease test or by
histopathology on biopsy specimens.
Preparation of freshly isolated gastric epithelium and T cells.
(i) Gastric epithelium.
To evaluate the expression of Fas
receptor, gastric epithelial cells were partially enriched using a
modification of previously described techniques (13, 53).
Briefly, biopsy specimens from subjects infected with H. pylori were collected into sterile collection medium (calcium- and
magnesium-free Hanks balanced salt solution [HBSS] with 5% fetal
calf serum [FCS] and penicillin plus streptomycin). Biopsy specimens
were rinsed with HBSS medium containing 1 mM dithiothreitol and 1 mM
EDTA (Sigma Chemical Co., St. Louis, Mo.). The specimens were agitated
for 1 h at 37°C to obtain epithelial cells. The resulting cell
suspensions were washed, and the viability of the gastric epithelial
cells was determined by trypan blue exclusion. Cells were not used if
viability did not exceed 80%. The yield from a single subject varied
from 5 × 105 to 1 × 106, so further
purification by density gradients was not possible. To determine
purity, freshly isolated cells were stained for an epithelium-specific
antigen using fluorescein isothiocyanate-conjugated monoclonal antibody
(clone Ber-EP4; Dako, Flostrup, Denmark) as previously described
(3, 17). Purity ranged from 50 to 80% with epithelial
lymphocytes being the major contaminating cell type (3).
Cells stained by the epithelial cell antigen were selected by
electronic gating, and this population was examined by flow cytometry
for the expression of Fas receptor.
(ii) Gastric T cells.
Gastric T cells were isolated using a
modification of previously described techniques (3, 12).
Briefly, biopsy specimens were collected into collection medium
(calcium- and magnesium-free HBSS with 5% FCS and penicillin plus
streptomycin). In some cases, biopsy specimens were stored at 4°C for
up to 18 h prior to processing, this having previously been shown
not to alter T-cell function. All manipulations were carried out using
aseptic techniques. Biopsy specimens were rinsed with aqueous Betadine
and immediately rinsed four times in collection medium before being
placed in collection medium containing 1 mM dithiothreitol and 1 mM
EDTA. The specimens were agitated for 1 h at 37°C to remove
intraepithelial lymphocytes and epithelial cells before being placed in
complete RPMI medium (RPMI 1640 medium with 10% FCS, penicillin, and
streptomycin) and washed three times. Subsequently, lamina propria T
cells were liberated by treatment with collagenase (30 U/ml; Sigma
Chemical Co.) in complete RPMI medium for 3 h. Undigested biopsy
material was removed, and the cells were washed three times with
complete RPMI medium. The resulting cell suspensions were washed, and
the viability of the mononuclear cells was determined by trypan blue exclusion. Cells were not used if viability did not exceed 90%.
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Helicobacter pylori Modulates
Lymphoepithelial Cell Interactions Leading to Epithelial Cell Damage
through Fas/Fas Ligand Interactions
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) and
tumor necrosis factor alpha (TNF-
), can increase the release of
proinflammatory cytokines, such as interleukin-8, from the epithelium
(52), as well as Fas and Fas ligand (FasL) (6).
Furthermore, these cytokines can also increase the expression of major
histocompatibility complex class II molecules by gastric epithelial
cells, thereby increasing the binding of H. pylori to
the gastric epithelium (13). As Th1 cells are associated with cell-mediated immune responses, they may also play a role in
damaging gastric tissues directly by triggering apoptosis in gastric epithelial cells.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Immunohistochemistry. (i) Cytokines.
For cytokine detection
studies, frozen sections were prepared from two biopsy specimens of the
gastric antrum from infected and uninfected subjects. Two sections were
examined from each biopsy. The slides were fixed in 4%
paraformaldehyde in phosphate-buffered saline (PBS; pH 7.4) for 10 min,
washed in PBS, air dried, and kept at
20°C until used. After
rehydration, the slides were treated with 0.1% saponin (Sigma Chemical
Co.) in PBS to permeabilize the cell membranes. Endogenous peroxidase
and biotin activities were blocked with 1%
H2O2 and 0.02% NaN3 in PBS and by
use of an avidin-biotin blocking kit (Vector Laboratories, Burlingame, Calif.), respectively. The slides were then incubated overnight at
4°C with anti-TNF-
(MAB11; PharMingen, San Diego, Calif.) or
anti-IFN-
(DIK-1; Chromogenix, Molndal, Sweden) monoclonal antibodies at a concentration of 5 µg/ml. An irrelevant
isotype-matched monoclonal antibody (Dako) was used as a control for
nonspecific staining. After blocking with 1% normal goat serum,
biotinylated goat anti-mouse IgG, absorbed against human IgG (Caltag
Laboratories, San Francisco, Calif.), was added as a secondary
antibody, and the mixture was incubated for 30 min at room temperature.
The sections were then overlaid with an avidin-biotin-horseradish peroxidase complex (Vectastain ABC-HP kit; Vector Laboratories), followed by the substrate chromagen diaminobenzidine (Vector
Laboratories), and finally counterstained with Mayer's hematoxylin.
(ii) FasL and FasR. Paraffin-embedded sections of normal gastric tissues were deparaffinized in xylene and rehydrated prior to analysis. Slides were washed twice for 5 min each time in a wash buffer containing 50 mM Tris-HCl (pH 7.6), 50 mM NaCl, and 0.001% saponin. Endogenous peroxidase was quenched with 3.0% hydrogen peroxide in methanol for 5 min. Slides were washed as before, except that the wash buffer for this and all subsequent steps included 1% normal goat serum, and then blocked for 1 h in a wash buffer containing 5% normal goat serum. After washing and incubation overnight at 4°C with affinity-purified rabbit polyclonal anti-human FasL- or FasR-specific IgG (Santa Cruz Biotechnology, Santa Cruz, Calif.) at 0.1 µg/ml in wash buffer, antibody binding was localized using a biotinylated secondary antibody, avidin-conjugated horseradish peroxidase, and diaminobenzidine substrate (contained within the Vectastain ABC-HP kit [Vector Laboratories]). The appropriate immunizing peptide to which the antibody was raised (FasL amino acids 260 to 279 or FasR amino acids 316 to 335; Santa Cruz Biotechnology) was included at 1 µg/ml during primary antibody incubation as a direct internal competitive control for antibody specificity. Slides were counterstained with hematoxylin.
Bacteria and human cell lines. H. pylori LC-11 is a cagA-bearing strain that was isolated from a child with duodenal ulceration as described previously (8, 11). To investigate the impact of the cag pathogenicity island (PAI) on the induction of Fas, strain 26695 and an isogenic mutant lacking the entire cag PAI, 8-1 (2), were used. Briefly, bacteria were grown on blood agar base (Becton Dickinson, San Jose, Calif.) at 37°C under microaerobic conditions and harvested on day 3 into PBS. After centrifugation at 2,500 × g for 15 min, bacteria were resuspended in sterile PBS (pH 7.4) to a concentration of 2 × 108/ml. Bacterial numbers were estimated by measuring the A530 using a DU-65 spectrophotometer (Beckman, Fullerton, Calif.). One unit of optical density at 530 nm (OD530) was equivalent to 2 × 108 bacteria per ml as determined by comparing the measured value to a standard curve generated by quantifying viable organisms from aliquots of bacteria at various concentrations that were also assessed for absorbance. Motility was confirmed by phase-contrast microscopy prior to experimental use.
Kato-III, N87, and AGS-NY2 are gastric epithelial cell lines, while Jurkat E6-1 is a leukemia T-cell line. Kato-III, N87, and Jurkat E6-1 cells were purchased from the American Type Culture Collection, Manassas, Va., while AGS-NY2 cells were generously provided by S. Moss. All cells were maintained in RPMI 1640 medium supplemented with 10% FCS as previously described (13).Examination of Fas receptor expression by flow cytometry. To measure Fas receptor expression, freshly isolated gastric epithelial cells were harvested, washed, and stained with an optimal amount of mouse anti-human Fas receptor (CD95) (DX2 at 1 µg/ml; PharMingen) or an appropriate isotype control. Subsequently, cells were washed with PBS with 0.1% bovine serum albumin and fixed in 1% paraformaldehyde in PBS before specific fluorescence was measured using a FACScan (Becton Dickinson) after correction for nonspecific fluorescence using the appropriate isotype controls. The results are presented as the mean fluorescence intensity (MFI) and percentage of positive cells.
In other experiments, resting or stimulated gastric epithelial cell lines were stained in an identical fashion for the evaluation of CD95 expression. Briefly, cells were exposed to the various strains of H. pylori (300 bacteria/epithelial cell), TNF-
(40 ng/ml; R&D Systems, Minneapolis, Minn.), or IFN-
(100 U/ml; R&D Systems) either alone or in combination. These cytokine concentrations were based on a previous determination of optimal responses as reported
by several laboratories (8, 13, 21, 24, 49). After
incubation for 48 h, the cells were harvested and Fas expression was detected by flow cytometry. The results are presented as the relative MFI, which equals (MFI of Fas/MFI of isotype) × 100, to
compare the changes in Fas expression.
To determine if functional Fas was expressed on gastric epithelial
cells, Kato-III, AGS-NY2, and N87 cells were incubated with medium or
various stimuli as described above for 6 h, followed by incubation
with medium or 30 to 100 ng of IgM anti-Fas antibody CH11 (Kamiya
Biomedical Company, Thousand Oaks, Calif.) per ml for 12 h. DNA
fragmentation was evaluated by enzyme-linked immunosorbent assay
(ELISA) and a DNA ladder assay as described below.
Detection of FasL mRNA. (i) Extraction of total RNA and reverse transcription (RT). Total RNA was extracted from gastric biopsy specimens or cell lines using Trizol reagent (Life Technologies, Houston, Tex.) in accordance with the protocol provided by the manufacturer (8). Briefly, cells or tissues were lysed using Trizol reagent, followed by extraction with chloroform and precipitation with isopropanol, washed one time using 70% ethanol, and then diluted into diethylpyrocarbonate-treated distilled water. The purity and amount of the RNA were determined by measuring OD260 and OD280 using a DU-65 spectrophotometer (Beckman). cDNA was synthesized using Superscript II reverse transcriptase and oligo(dT)s primer (Life Technologies, Gaithersburg, Md.) at 42°C in accordance with the protocol provided by the manufacturer.
Amplification of FasL.
Primers for FasL were designed in
accordance with the human gene sequences as described elsewhere
(37). The length of the product is 344 bp.
-Actin primers
were purchased from Clontech Laboratory (Palo Alto, Calif.); the length
of the product is 838 bp. The sequences of FasL primers were as
follows: sense primer, 5'-CAGCTCTTCCACCTACAGAAGG-3';
antisense primer, 5'-GAGAGACCAGTTAAAACTCCTTAGA-3'. Thermal cycling was done as follows: denaturation at 96°C for 15 s, annealing at 55°C for 30 s, and extension at 72°C
for 150 s; 40 cycles were performed. Primers were used at a final
concentration of 0.1 µM each in a 50-µl volume, and the
concentration of Mg2+ was 1.0 mM. PCR products were
identified after separation by electrophoresis using 1.2% agarose
gels, followed by staining with ethidium bromide.
Detection of DNA fragmentation. (i) JAM test.
Induction of
apoptosis was detected using a cytotoxicity assay termed the
JAM test (33). Briefly, target cells (T) were labeled with
[3H]thymidine (ICN Pharmaceuticals Inc., Irvine, Calif.)
at 10 µCi/ml for 12 h and seeded into 96 wells at a
concentration of 2 × 104 cells per well. Effector
cells (E) were cocultured with targets at various E/T ratios for
12 h. Subsequently, cells were collected with a cell harvester
(Skatron Instruments Inc., Sterling, Va.) and radioactivity was
determined using a liquid scintillation counter (Beckman). The degraded
DNA was washed through the membrane, and the undegraded,
high-molecular-weight DNA was captured on the membrane. Thus, killing
(expressed as the percentage of killed cells) can be calculated as
(S
E)/S × 100, where S is counts per minute in the medium control and E is the counts per
minute of treated cells.
(ii) ELISA. DNA fragmentation was also measured using a commercially available ELISA (Boehringer, Mannheim, Germany). This assay detects low-molecular-weight nucleosome fragments in the cytoplasmic fractions of affected cells that arise during apoptosis but not as a result of necrosis. A405 was measured by Titertek Multiskan MCC/340 (ICN Pharmaceuticals Inc.) and compared to that of the substrate solution used as a blank. The apoptotic index was calculated in accordance with the manufacturer's instructions by dividing the absorbance of stimulated cells by the absorbance of control cells (13).
Gel electrophoresis. Agarose gel electrophoresis to detect DNA fragmentation was conducted in accordance with a standard procedure for assaying fragmentation in total genomic DNA (48). Briefly, cells under different culture conditions were harvested and pelleted by centrifugation at 400 × g for 5 min. Subsequently, 106 epithelial cells were washed with PBS, pelleted, and resuspended in sample buffer composed of Tris-buffered glycerol with ZnSO4 at 1.4 mg/ml, bromophenol blue, and RNase (Sigma) at 10 mg/ml. Nucleosomal ladders were visualized in 2% agarose gels in TBE buffer (0.09 M Tris, 0.09 mM boric acid, 0.24 M EDTA, pH 8.0). Cells were lysed by 2% sodium dodecyl sulfate and proteinase K (Sigma) at 53 µg/ml contained within a 1% agarose gel slice above the wells. The gel was run for 10 to 14 h at 30 V, stained with ethidium bromide at 2 µg/ml for 1 h, and washed overnight with a large volume of distilled water to remove excess stain. UV light was used to visualize DNA fragments in the gel that were photographed, and their migration was compared to that of the HaeIII-digested fX174 standard (Promega, Madison, Wis.).
Statistical analyses. Results are expressed as the mean ± the standard error of the mean (SEM). Fas/FasL expression and killing rates were compared using a two-tailed Student t test, and differences were considered significant if P values were <0.05.
| |
RESULTS |
|---|
|
|
|---|
Gastric epithelial cells express Fas receptor in vivo.
In
order for gastric T cells to mediate epithelial cell death through
Fas/FasL interactions, the target cell must express Fas. To confirm the
expression of Fas by gastric epithelium and to compare the expression
on gastric epithelial cells in the presence or absence of H. pylori infection, gastric biopsy specimens were collected from
infected and uninfected subjects and isolated epithelial cells were
examined by flow cytometry (Fig. 1A).
After staining to detect surface Fas, the MFI was 19.0 in eight
infected subjects versus 7.8 in eight uninfected subjects, while the
mean percentage of Fas-positive cells was 11.3% versus 1.4%,
respectively (P < 0.05). Since the expression of Fas
was restricted to a small subset of the isolated epithelial cells from
infected subjects, the distribution of Fas expression was examined by
immunohistochemistry. Consistent with the findings obtained using flow
cytometry, Fas expression was limited to an extremely small percentage
of the gastric epithelial cells in normal, uninfected specimens (data
not shown) whereas Fas expression by epithelial cells from infected
tissues was much greater (Fig. 1B). Thus, Fas expression by gastric
epithelial cells is increased during infection with H. pylori.
|
Th1 cytokine production adjacent to the gastric epithelium.
Since Fas expression on epithelial cells was increased and this can be
achieved by cytokines from Th1 cells, the expression of IFN-
and
TNF-
adjacent to gastric epithelial cells was examined by
immunohistochemistry. IFN-
-positive cells were found in all but one
of the H. pylori-infected subjects, whereas TNF-
was found in five of eight infected biopsy specimens. IFN-
or TNF-
was never found in biopsy specimens from healthy uninfected
subjects using this approach. As shown in Fig.
2, both cytokines were detected in
mononuclear cells within, or adjacent to, the gastric epithelium. The
median number of IFN-
-stained intraepithelial lymphocytes was
1.7/mm2 of tissue area (interquartile range, 0.8 to 4), and
the median number of positively stained lamina propria was 4.8 (interquartile range, 1.8 to 11). TNF-
-positive cells, median
number, 1.2 (interquartile range, 0 to 2.9), were often located in the
lamina propria surrounding the neck region of the gastric glands, but
no intraepithelial lymphocytes were specifically stained for TNF-
.
Interestingly, positive staining for both cytokines was occasionally
also found in the epithelial cells themselves. The finding of IFN-
and TNF-
-positive cells was consistent with the reports describing
the cytokine production in gastric tissue during infection (3, 9,
26, 31) and suggested a potential role for Th1 cells in the
regulation of Fas/FasL interactions.
|
Regulation of Fas expression on gastric epithelial cells by
H. pylori and Th1 cytokines.
Since Th1 cytokines
are present adjacent to the gastric epithelium in H. pylori-infected tissues, we determined if these factors might
account for the observed increase in Fas expression by gastric epithelial cells. Gastric epithelial cell lines were stimulated with
H. pylori in the presence or absence of various
cytokines and examined by flow cytometry. Figure
3A shows that Fas expression on three
separate gastric epithelial cell lines was increased by IFN-
, with
Kato-III being the most sensitive cell line. In another experiment, Fas
expression on Kato-III cells was detected after incubation with
H. pylori, IFN-
, and TNF-
, either alone or in
various combinations. Figure 3B shows that Fas expression on Kato-III
cells was increased consistently by all of these stimuli alone while
the combination of H. pylori, IFN-
, and TNF-
yielded the greatest induction of Fas. To investigate the role of the cag PAI in the induction of Fas, Kato-III, AGS-NY2, and N87
cells were incubated with strain 26695 or the cag
PAI-deficient isogenic mutant 8-1. As shown in Table
1, both strains induced Fas expression although the level of induction was greater with cag-bearing
strain 26695.
|
|
Fas expressed by gastric epithelium is functional.
The
function of Fas expressed on three separate gastric epithelial cell
lines was examined after control or IFN-
-treated cells were
incubated with anti-Fas IgM antibody. DNA degradation products isolated
from the cytosol of stimulated and control cells were evaluated by an
ELISA to detect DNA fragments released from the nuclei of cells
undergoing apoptosis. Figure 4A
shows that the ELISA used was able to detect DNA fragmentation induced
during apoptosis in as few as 10 cells. IFN-
and anti-Fas
antibody alone killed gastric epithelial cells; however, the
combination of both markedly increased the apoptosis of gastric
epithelial cells. Figure 4B shows the low-molecular-weight DNA isolated
from Kato-III cells (106/ml) resolved on a 2% agarose gel
after control or IFN-
-treated cells were incubated with anti-Fas IgM
antibody and not an isotype control antibody. Moreover, Fas was shown
to be functional on other cell lines, including AGS-NY2 and N87 (Table
2). Significant augmentation of killing
(P < 0.05) was observed in all lines treated with
IFN-
and in AGS-NY2 or N87 cells exposed to H. pylori 26695 but not under the other conditions tested. These
findings indicate that innately expressed Fas and IFN-
-induced Fas
are functional in the transduction of the apoptotic signal.
|
|
FasL is expressed in gastric tissues.
To determine if
Fas-bearing epithelial cells would be exposed to effector cells
expressing FasL, gastric biopsy specimens from infected or
uninfected subjects were examined for FasL protein by
immunohistochemistry. As shown in Fig.
5A, FasL protein was present on
mononuclear cells in the gastric mucosa of infected individuals,
whereas the expression in normal uninfected tissues was undetectable
(M. Bennett et al., unpublished observations). To detect FasL mRNA,
total RNA of gastric biopsy specimens with or without H. pylori infection was extracted and assayed using RT-PCR. As shown
in Fig. 5B, all four infected gastric tissues contained mRNA for FasL
while only one weakly positive band was detected in the three
uninfected biopsy specimens.
|
Functional FasL is expressed by gastric T cells.
Gastric T
cells were isolated from biopsy specimens and expanded in vitro in
order to evaluate the expression and function of FasL. As shown in Fig.
6A, FasL mRNA was detected by RT-PCR in
gastric T cells isolated from H. pylori-infected
individuals. To evaluate the function of FasL, the T-cell lines were
assayed using the JAM test to determine if they induced
apoptosis in Jurkat T-cell line E6-1. The Jurkat E6.1 clone
expressed a high level of Fas and was susceptible to IgM anti-Fas
(CH11) antibody-mediated killing (data not shown). As shown in Fig. 6B,
gastric T-cell lines could kill these target cells and this
cytotoxicity was inhibited by antibody ZB4, which blocks Fas/FasL
interactions while an isotype control, mouse IgG, did not (P < 0.05). These results imply that FasL expressed by T cells in
the stomach during H. pylori infection was capable of
mediating apoptosis in Fas-bearing cells.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Diseased tissue is often associated with cell death due to various
processes, including necrosis and apoptosis. Apoptosis is a
normal mechanism that controls epithelial cell turnover; however, the
rate of apoptosis can be altered in response to infection and
inflammation. Induction of apoptosis by H. pylori has been reported in subjects with duodenal ulcer and
gastritis (25). Jones et al. found that the apoptotic index
increased threefold in persons with H. pylori gastritis
compared to noninflamed controls, and this change decreased following
the eradication of H. pylori and resolution of
gastritis (25). Other authors have described an increase in
both the proliferation rate and the apoptotic index in H. pylori-infected stomachs (4, 29, 39). These
observations imply that during infection with H. pylori, gastric epithelial apoptosis is induced and
followed by an increase in the repair process. However, the mechanisms
regulating cell death have only begun to be defined. Recently, it has
been shown that H. pylori can induce apoptosis
directly (13, 24, 41, 49). In addition, some cytokines, such
as TNF-
or IFN-
, can induce apoptosis directly, as well
as augment the effects of the bacteria alone (13, 49). The
results presented here provide evidence that T cells can contribute to
epithelial cell death through Fas/FasL interactions.
IFN-
-producing T cells, both CD4+ and CD8+,
have been reported to be increased in the gastric mucosa of infected
subjects (3, 17). Importantly, D'Elios and colleagues have
shown that some gastric Th1 cell lines specifically recognize
H. pylori antigens and produce both TNF-
and IFN-
(9). More recent immunohistochemical evidence suggests that
cytokine-producing Th1 cells predominate in the gastric antral mucosa
during infection (31, 44). In addition, Th1 cells also
dominate in the healthy uninfected gastric mucosa (17) or in
a state of gastritis for other reasons (26). Thus, the
predominance of Th1 cells suggests that local T cells contribute
significantly to cell-mediated immunity targeted toward the epithelium
during gastritis for various reasons.
One mechanism by which T cells kill their targets is expression of FasL and its binding to the Fas receptor. This mechanism of killing can be achieved by both CD8+ cytotoxic T lymphocytes, as well as CD4+ Th1 cells (18, 46, 51). T cells isolated from gastric tissues and expanded in vitro expressed FasL mRNA and were capable of inducing apoptosis in target cells bearing Fas. Unfortunately, too few T cells were isolated from gastric biopsy specimens to permit direct evaluation of FasL expression and function, therefore requiring the activation in vitro that may have induced FasL expression artificially. However, RT-PCR showed that FasL expression was increased in gastric tissue and immunohistochemistry confirmed the increase in FasL protein, including its expression on mononuclear cells adjacent to the epithelium. These data provide a human correlate of Fas/FasL-mediated epithelial cell damage that occurs in response to lymphoepithelial interactions in mice (16, 23, 30, 42, 45). Thus, epithelial cell damage may play a role in the pathogenesis of gastrointestinal disease in humans, as well as in the animal models studied to date.
In order for T cells bearing FasL to mediate apoptosis in gastric epithelial cells, the target must express the Fas receptor. Fas is expressed on T cells and is a key factor in the differentiation of T cells and prevention of autoimmune diseases. However, Fas can be expressed by a variety of cells that can be damaged by T cells expressing FasL and has therefore been associated with the development of some autoimmune diseases (5). For example, it has been found that Fas is involved in the development of murine autoimmune gastritis (36).
Previous reports have described the expression of Fas on gastric epithelial cell lines (19, 21, 24, 28). Moreover, Fas molecules on the surface of gastric epithelial cells can be stimulated to induce apoptosis (19, 22, 24). Rudi et al. recently reported that cagA+ H. pylori strains can upregulate the expression of Fas and FasL on gastric tissues, and this may contribute to the apoptosis during infection (41). In our study, gastric epithelial cells expressed Fas both in vivo and in vitro, verifying that they can serve as target cells in Fas-mediated cell death. Approximately 20% of the freshly isolated cells expressed Fas, as detected by fluorescence-activated cell sorter. Immunohistochemistry supported the fluorescence-activated cell sorter findings by demonstrating that Fas expression on gastric epithelial cells in gastric biopsy specimens from infected subjects was higher than that in uninfected tissues. Furthermore, the high levels of Fas expression were unevenly distributed, preferentially in the neck of the stomach. This is the region in which cytokine-producing T cells are enriched (3), suggesting that induction of Fas is greatest adjacent to cytokine-producing cells.
Th1 cytokines (52), including IFN-
and TNF-
, and
H. pylori infection (15, 27, 34, 43, 47)
activate transcription factors in gastric epithelial cells that bind to
the NF-
B and AP-1 regulatory sites. Since these regulatory sites are
located in the 5' region of the fas gene, it is possible
that both can contribute to the induction of Fas expression. However,
our results showed that H. pylori strain 8-1, which
lacks the cag PAI, induced Fas expression, although to a
lesser degree. Since the activation of NF-
B by H. pylori is dependent on the presence of the cag PAI
(15, 52), AP-1 likely plays a role in the induction of Fas.
Possibly, other transcription factors play a role but remain to be defined.
Three different cell lines expressing Fas were susceptible to
apoptosis after being exposed to anti-Fas antibodies and/or T
cells expressing FasL. Interestingly, the ability to detect apoptosis was dependent on the assay being used. Based on the detection of DNA fragmentation using electrophoresis, apoptosis could only be detected after pretreatment with IFN-
to increase the
expression of Fas. This is similar to another observation using
intestinal epithelial cell lines (1). However, using the
ELISA or the JAM test, apoptosis could be detected without boosting the expression of Fas. Therefore, cytokines can not only induce apoptosis directly but also increase the expression of Fas and enhance cell death by Fas/FasL interactions. It remains to be
determined if some of the synergism is due to the effect of cytokines
on signaling pathways that "arm" the cell to respond more
efficiently subsequent to the engagement of the Fas receptor.
Further evidence in support of the notion that gastric T-cell cytokines
collaborate in the regulation of epithelial cell death is found in the
presence of IFN-
- and TNF-
-producing cells within the gastric
mucosa. IFN-
and TNF-
are known to increase Fas expression on
several types of cells, including renal endothelium (38),
intestinal epithelium (50), and astrocytes (6).
We found that these Th1 cytokines could act synergistically with H. pylori to increase Fas expression on all three of
the gastric epithelial cell lines tested (AGS-NY2, Kato-III, and N87),
which extends previous observations describing the regulation of Fas on
gastric epithelial cells (24). Thus, Th1 cytokines can not only injure the gastric epithelium directly (13, 49) but
also accelerate epithelial damage by modulating Fas/FasL interactions.
In conclusion, H. pylori infection induces the expansion of Th1-like cells that have the potential to express FasL. T cells with this phenotype can increase the expression of Fas on gastric epithelial cells and induce cell death through Fas/FasL interactions. Thus, apoptosis of the gastric epithelium can occur due to multiple mechanisms and thereby lead to a breach in the epithelial barrier that facilitates tissue damage due to luminal acid and pepsin.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by NIH grants DK 50669, DK 51577, and CHD 35741 and a John Sealy Memorial Endowment development grant. X.F. is a recipient of a McLaughlin Fellowship. F. Shanahan, M. Bennett, and J. O'Connell are supported in part by the Health Research Board of Ireland. J. O'Connoll is supported by the Wellcome Trust.
We thank Kim Palkowetz for her technical assistance with flow cytometry.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Children's Hospital Rm 2.300, UTMB, 301 University Blvd., Galveston, TX 77555-0366. Phone: (409) 772-1750. Fax: (409) 772-1761. E-mail: Pernst{at}utmb.edu.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Abreu-Martin, M. T.,
A. Vidrich,
D. H. Lynch, and S. R. Targan.
1995.
Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF- and ligation of Fas antigen.
J. Immunol.
155:4147-4154[Abstract].
|
| 2. | Akopyants, N. S., S. W. Clifton, D. Kersulyte, J. E. Crabtree, B. E. Youree, C. A. Reece, N. O. Burkanov, E. S. Drazek, B. A. Roe, and D. E. Berg. 1998. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol. Microbiol. 28:37-53[CrossRef][Medline]. |
| 3. | Bamford, K. B., X. J. Fan, S. E. Crowe, J. F. Leary, W. K. Gourley, G. K. Luthra, E. G. Brooks, D. Y. Graham, V. E. Reyes, and P. B. Ernst. 1998. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482-492[CrossRef][Medline]. |
| 4. | Bechi, P., M. Balzi, A. Becciolini, A. Maugeri, C. C. Raggi, A. Amorosi, and R. Dei. 1996. Helicobacter pylori and cell proliferation of the gastric mucosa: possible implications for gastric carcinogenesis. Am. J. Gastroenterol. 91:271-276[Medline]. |
| 5. | Brunner, T., and C. Mueller. 1999. Is autoimmunity coming to a Fas(L) end? Nat. Med. 5:19-20[CrossRef][Medline]. |
| 6. |
Choi, C.,
J. Park,
J. Lee,
J. H. Lim,
E. C. Shin,
Y. S. Ahn,
C. H. Kim,
S. J. Kim,
J. Kim,
I. S. Choi, and K. L. Choi.
1999.
Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.
J. Immunol.
162:1889-1895 |
| 7. |
Correa, P., and M. J. S. Miller.
1998.
Carcinogenesis, apoptosis and cell proliferation.
Br. Med. Bull.
54:151-162 |
| 8. | Crowe, S. E., L. Alvarez, P. M. Sherman, Y. Jin, M. Dytoc, R. H. Hunt, J. Patel, M. J. Muller, and P. B. Ernst. 1995. Expression of interleukin-8 and CD54 by human gastric epithelium after H. pylori infection in vitro. Gastroenterology 108:65-74[CrossRef][Medline]. |
| 9. | D'Elios, M. M., M. Manghetti, M. De Carli, F. Costa, C. T. Baldari, D. Burroni, J. Telford, S. Romagnani, and G. Del Prete. 1997. T helper 1 effector cells specific for Helicobacter pylori in gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962-967[Abstract]. |
| 10. | Dixon, M. F. 1994. Pathophysiology of Helicobacter pylori infection. Scand. J. Gastroenterol. 29:7-10[Medline]. |
| 11. |
Dytoc, M.,
B. Gold,
M. Louie,
M. Huesca,
L. Fedorko,
S. Crowe,
C. Lingwood,
J. Brunton, and P. Sherman.
1992.
Comparison of Helicobacter pylori and attaching-effacing Escherichia coli adhesion to eukaryotic cells.
Infect. Immun.
61:448-456 |
| 12. |
Fan, X. J.,
A. Chua,
C. N. Shahi,
J. McDevitt,
P. W. N. Keeling, and D. Kelleher.
1994.
Gastric T lymphocyte response to Helicobacter pylori in patients with H. pylori colonisation.
Gut
35:1379-1384 |
| 13. |
Fan, X. J.,
S. E. Crowe,
S. Behar,
H. Gunasena,
G. Ye,
H. Haeberle,
N. Van Houten,
W. K. Gourley,
P. B. Ernst, and V. E. Reyes.
1998.
The effect of class II MHC expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for Th1 cell-mediated damage.
J. Exp. Med.
187:1659-1669 |
| 14. | Genta, R. M., G. M. Lew, and D. Y. Graham. 1993. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod. Pathol. 6:281-289[Medline]. |
| 15. |
Glocker, E.,
C. Lange,
A. Covacci,
S. Bereswill,
M. Kist, and H. L. Pahl.
1998.
Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF- B activation.
Infect. Immun.
66:2346-2348 |
| 16. | Guy-Grand, D., J. P. DiSanto, P. Henchoz, M. Malassis-Seris, and P. Vassalli. 1998. Small bowel enteropathy: role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal. Eur. J. Immunol. 28:730-744[CrossRef][Medline]. |
| 17. | Haeberle, H. A., M. Kubin, K. B. Bamford, R. Garofalo, D. Y. Graham, F. El-Zaatari, R. Karttunen, S. E. Crowe, V. E. Reyes, and P. B. Ernst. 1997. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect. Immun. 65:4229-4235[Abstract]. |
| 18. | Hahn, S., R. Gehri, and P. Erb. 1995. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol. Rev. 146:57-79[CrossRef][Medline]. |
| 19. | Hayashi, H., S. Tatebe, M. Osaki, A. Goto, Y. Suzuki, and H. Ito. 1997. Expression of Fas antigen and its mediation of apoptosis in human gastric cancer cell lines. Jpn. J. Cancer Res. 88:49-55[CrossRef][Medline]. |
| 20. | Hopkins, R. J., L. S. Girardi, and E. A. Turney. 1996. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 110:1244-1252[CrossRef][Medline]. |
| 21. | Houghton, J., R. M. Korah, M. R. Condon, and K. H. Kim. 1999. Apoptosis in Helicobacter pylori-associated gastric and duodenal ulcer disease is mediated via the Fas antigen pathway. Dig. Dis. Sci. 44:465-478[CrossRef][Medline]. |
| 22. |
Houghton, J.,
L. S. Macera-Bloch,
L. Harrison,
K. H. Kim, and R. M. Korah.
2000.
Tumor necrosis factor alpha and interleukin 1 up-regulate gastric mucosal Fas antigen expression in Helicobacter pylori infection.
Infect. Immun.
68:1189-1195 |
| 23. | Inagaki-Ohara, K., H. Nishimura, T. Sakai, D. H. Lynch, and Y. Yoshikai. 1997. Potential for involvement of Fas antigen/Fas ligand interaction in apoptosis of epithelial cells by intraepithelial lymphocytes in murine small intestine. Lab. Investig. 77:421-429[Medline]. |
| 24. |
Jones, N. L.,
A. S. Day,
H. A. Jennings, and P. M. Sherman.
1999.
Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression.
Infect. Immun.
67:4237-4242 |
| 25. | Jones, N. L., P. T. Shannon, E. Cutz, H. Yeger, and P. M. Sherman. 1997. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am. J. Pathol. 151:1695-1703[Abstract]. |
| 26. |
Karttunen, R.,
T. Karttunen,
H.-P. T. Ekre, and T. T. MacDonald.
1995.
Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis.
Gut
36:341-345 |
| 27. |
Keates, S.,
Y. S. Hitti,
M. Upton, and C. P. Kelly.
1997.
Helicobacter pylori activate NF B in gastric epithelial cells.
Gastroenterology
113:1099-1109[CrossRef][Medline].
|
| 28. | Kume, T., K. Oshima, Y. Yamashita, T. Shirakusa, and M. Kikuchi. 1999. Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach. Int. J. Cancer 84:339-343[CrossRef][Medline]. |
| 29. | Li, H., B. Mellgard, and I. M. Helander. 1999. Inoculation of VacA- and CagA-Helicobacter pylori delays gastric ulcer healing in the rat. Scand. J. Gastroenterol. 32:439-444[CrossRef]. |
| 30. | Lin, T., T. Brunner, B. Tietz, J. Madsen, E. Bonfoco, M. Reaves, M. Huflejt, and D. R. Green. 1998. Fas ligand-mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease. J. Clin. Investig. 101:570-577[Medline]. |
| 31. |
Lindholm, C.,
M. Quiding-Järbrink,
H. Lönroth,
A. Hamlet, and A.-M. Svennerholm.
1998.
Local cytokine response in Helicobacter pylori-infected subjects.
Infect. Immun.
66:5964-5971 |
| 32. |
Mannick, E. E.,
L. E. Bravo,
G. Zarama,
J. L. Realpe,
X.-J. Zhang,
B. Ruiz,
E. T. H. Fontham,
R. Mera,
M. J. S. Miller, and P. Correa.
1996.
Inducible nitric oxide synthase, nitrotyrosine and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants.
Cancer Res.
56:3238-3243 |
| 33. | Matzinger, P. 1991. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145:185-192[CrossRef][Medline]. |
| 34. | Meyer-Ter-Vehn, T., A. Covacci, M. Kist, and H. L. Pahl. Helicobacter pylori activates MAP kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J. Biol. Chem., in press. |
| 35. |
Moss, S. F.,
J. Calam,
B. Agarwal,
S. Wang, and P. G. Holt.
1996.
Induction of gastric epithelial apoptosis by Helicobacter pylori.
Gut
38:498-501 |
| 36. | Nishio, A., K. Katakura, C. Toshima, S. Kasakura, M. Sakai, S. Yonehara, T. Suda, S. Nagata, and T. Masuda. 1996. A possible involvement of Fas-Fas ligand signaling in the pathogenesis of murine autoimmune gastritis. Gastroenterology 111:959-967[CrossRef][Medline]. |
| 37. |
O'Connell, J.,
G. C. O'Sullivan,
J. K. Collins, and F. Shanahan.
1996.
The Fas counter-attack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
J. Exp. Med.
184:1075-1082 |
| 38. |
Ortiz-Arduan, A.,
T. M. Danoff,
R. Kalluri,
S. Gonzalez-Cuadrado,
S. L. Karp,
K. Elkon,
J. Egido, and E. G. Neilson.
1996.
Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia.
Am. J. Physiol.
271:F1193-1201 |
| 39. | Piotrowski, J., E. Piotrowski, D. Skrodzka, A. Slomiany, and B. L. Slomiany. 1997. Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand. J. Gastroenterol. 32:203-211[Medline]. |
| 40. |
Ramsdell, F.,
M. S. Seaman,
R. E. Miller,
K. S. Picha,
M. K. Kennedy, and D. H. Lynch.
1994.
Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death.
Int. Immunol.
6:1545-1553 |
| 41. | Rudi, J., D. Kuck, S. Strand, A. Von Herbay, S. M. Mariani, P. H. Krammer, P. R. Galle, and W. Stremmel. 1998. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J. Clin. Investig. 102:1506-1514[Medline]. |
| 42. | Sakai, T., Y. Kimura, K. Inagaki-Ohara, K. Kusugami, D. H. Lynch, and Y. Yoshikai. 1997. Fas-mediated cytotoxicity by intestinal intraepithelial lymphocytes during graft-versus-host disease in mice. Gastroenterology 113:168-174[CrossRef][Medline]. |
| 43. |
Sharma, S. A.,
M. K. Tummuru,
M. J. Blaser, and L. D. Kerr.
1998.
Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells.
J. Immunol.
160:2401-2407 |
| 44. |
Sommer, F.,
G. Faller,
P. Konturek,
T. Kirchner,
E. G. Hahn,
J. Zeus,
M. Röllinghoff, and M. Lohoff.
1998.
Antrum- and corpus mucosa-infiltrating CD4+ lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype.
Infect. Immun.
66:5543-5546 |
| 45. |
Stuber, E.,
A. Buschenfeld,
A. von Freier,
T. Arendt, and U. R. Folsch.
1999.
Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor alpha and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy.
Gut
45:229-235 |
| 46. | Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806-3813[Abstract]. |
| 47. |
van Den Brink, G. R.,
F. J. ten Kate,
C. Y. Ponsioen,
M. M. Rive,
G. N. Tytgat,
S. J. van Deventer, and M. P. Peppelenbosch.
2000.
Expression and activation of NF-kappa B in the antrum of the human stomach.
J. Immunol.
164:3353-3359 |
| 48. | Van Houten, N., and R. C. Budd. 1992. Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes. J. Immunol. 149:2513-2517[Abstract]. |
| 49. | Wagner, S., W. Beil, J. Westermann, R. P. H. Logan, C. T. Bock, C. Trautwein, J. S. Bleck, and M. P. Manns. 1997. Regulation of epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 113:1836-1847[CrossRef][Medline]. |
| 50. |
Xu, X.,
X. Y. Fu,
J. Plate, and A. S. Chong.
1999.
IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression.
Cancer Res.
58:2832-2837 |
| 51. |
Yagita, H.,
S. Hanabuchi,
Y. Asano,
T. Tamura,
H. Nariuchi, and K. Okumura.
1995.
Fas-mediated cytotoxicity a new immunoregulatory and pathogenic function of Th1 CD4+ T cells.
Immunol. Rev.
146:223-239[CrossRef][Medline].
|
| 52. |
Yasumoto, K.,
S. Okamoto,
N. Mukaida,
S. Murakami,
M. Mai, and K. Matsushima.
1992.
Tumor necrosis factor and interferon synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kappaB-like binding sites of the interleukin 8 gene.
J. Biol. Chem.
267:22506-22511 |
| 53. | Ye, G., C. Barrera, X. J. Fan, S. E. Crowe, P. B. Ernst, and V. E. Reyes. 1997. Gastric epithelial cells express the costimulatory molecules B7.1 and B7.2 during infection with Helicobacter pylori and activate CD4 T cells. J. Clin. Investig. 99:1628-1636[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»